NDC 0061-5432 - Mometamax Single
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-5432
- Package NDCs from labels
- 0061-5432-01
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2025-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| gentamicin, posaconazole, and mometasone furoate otic suspension | Merck Sharp & Dohme Corp. | 2025-05-06 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-5432-01 | Mometamax Single | 1 in 1 CARTON | SUSPENSION | 1 | 1 | |
| 0061-5432-01 | Mometamax Single | 24 mL in 1 BOTTLE, DISPENSING | SUSPENSION | 24 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allergy | MOMETASONE FUROATE | Amazon.com Services LLC | b4d548fa-374d-407f-8a41-f04bf6a0e7a4 | 2026-08-27 | Warnings | MTW0WEG809 |
| Nasonex | MOMETASONE FUROATE | L. Perrigo Company | 13696a8b-366a-4a5e-adea-d5b7bff9e46f | 2026-08-19 | Warnings | MTW0WEG809 |
| POSACONAZOLE | POSACONAZOLE | Aurobindo Pharma Limited | f8a26673-261c-4e8e-b1e1-9e23aaf7f285 | 2026-08-03 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Ryaltris | OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | Glenmark Pharmaceuticals Inc., USA | 406be932-f00e-4c66-9dd1-c142090fe822 | 2026-07-21 | Warnings, Adverse reactions | MTW0WEG809 |
| posaconazole | POSACONAZOLE | Mylan Institutional LLC | 1ebbd88b-547b-4b49-ab73-98094a2d5a79 | 2026-07-15 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Posaconazole | POSACONAZOLE | Dr.Reddys Laboratories Inc | d8d8dd03-46b5-bd26-bb27-7ca31d8c3326 | 2026-06-25 | Warnings, Adverse reactions | 6TK1G07BHZ |
| topcare allergy | MOMETASONE FUROATE MONOHYDRATE | Topco Associates LLC | 9e7c759e-d2cb-4505-ad9f-38efaaaeefc2 | 2026-06-11 | Warnings | MTW0WEG809 |
| posaconazole | POSACONAZOLE | Gland Pharma Limited | 52d9d29e-4a37-4926-aa57-8477f5447b34 | 2026-06-09 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Allergy | MOMETASONE FUROATE MONOHYDRATE | Rite Aid Corporation | ec864592-bcee-4f45-97e8-34b28fe9e1a4 | 2026-06-03 | Warnings | MTW0WEG809 |
| POSACONAZOLE | POSACONAZOLE | Major Pharmaceuticals | 8e1e69b8-cf41-47cc-a3ec-1baee55f099a | 2026-06-01 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Hospira, Inc. | 977180b3-a222-4282-d485-4a3217674305 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| posaconazole | POSACONAZOLE | Hikma Pharmaceuticals USA Inc. | 282ddea7-47d8-44e4-8806-169d7cafa951 | 2026-05-18 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cardinal Health 107, LLC | 5113bfad-42ca-4bb8-9343-0b08c6cd03f0 | 2026-05-08 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| POSACONAZOLE | POSACONAZOLE | Lupin Pharmaceuticals, Inc. | 548124ce-8050-46a9-967b-ff23dfb18633 | 2026-05-07 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Preferred Pharmaceuticals Inc. | 5ac8ea7a-ee89-49f5-8d30-6dbb56503d94 | 2026-05-05 | Warnings, Adverse reactions | 8X7386QRLV |
| POSACONAZOLE | POSACONAZOLE | SpecGx LLC | 8412398b-c696-4f12-ba3a-da74dc8dadaf | 2026-04-23 | Warnings, Adverse reactions | 6TK1G07BHZ |
| POSACONAZOLE | POSACONAZOLE | ATLANTIC BIOLOGICALS CORP. | dfbc636f-d8a7-4232-a6b0-cda49caadc9b | 2026-04-20 | Warnings, Adverse reactions | 6TK1G07BHZ |
| allergy | MOMETASONE FUROATE MONOHYDRATE | HyVee Inc | 9f83880b-0062-433a-bc4a-00886b975dd3 | 2026-03-29 | Warnings | MTW0WEG809 |
| Posaconazole | POSACONAZOLE | Amneal Pharmaceuticals NY LLC | 5f795eca-7a03-4c91-9a0e-c1235791b665 | 2026-03-20 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Gentamicin Sulfate Opth Solution | GENTAMICIN SULFATE OPTH SOLUTION | Direct_Rx | e1a5bc32-f9a0-6b33-e053-2995a90ab9ac | 2026-03-17 | Warnings, Adverse reactions | 8X7386QRLV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.